We are live on ! Find out more
REVS icon

Columbia Research Enhanced Value ETF
REVS

4 hedge funds and large institutions have $676K invested in Columbia Research Enhanced Value ETF in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding

Funds holding: 1 → 4 (+3)

254% more capital invested

Capital invested by funds: $191K → $676K (+$485K)

8.05% more ownership

Funds ownership: 5.57% → 13.62% (+8%)

Holders
4
Holders Change
+3
Holders Change %
+300%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$315K
2
Truist Financial
Truist Financial
North Carolina
+$283K
3
HI
Harbour Investments
Wisconsin
+$147K
4
Osaic Holdings
Osaic Holdings
Arizona
+$7.34K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
1
Harbour Investments
Wisconsin
$351K +$147K +7,375 +74%
Envestnet Asset Management
2
Envestnet Asset Management
Illinois
$318K +$315K +15,757 New
Osaic Holdings
3
Osaic Holdings
Arizona
$7K +$7.34K +367 New
Truist Financial
4
Truist Financial
North Carolina
– +$283K +14,144 New

REVS Hedge Fund Activity: Q2 2021 in Review

4 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Value ETF (REVS) for Q2 2021, worth a combined $676K — up 254% from $191K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new REVS positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Envestnet Asset Management, opening a new position worth an estimated $315K.

  • 4 institutional investors held Columbia Research Enhanced Value ETF (REVS) as of Q2 2021, up from 1 in Q1 2021.
  • Funds reported $676K of Columbia Research Enhanced Value ETF stock for Q2 2021, up 254% quarter-over-quarter.
  • 3 funds opened new Columbia Research Enhanced Value ETF positions in Q2 2021 and 0 closed out, a net change of +3 holders.
  • The largest Columbia Research Enhanced Value ETF buyer in Q2 2021 was Envestnet Asset Management, an estimated $315K added.

Based on aggregated 13F filings for Q2 2021.